Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Norwegian School of Sport Sciences | OTHER |
| Gjensidigestiftelsen | UNKNOWN |
| The Research Council of Norway | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to determine the feasibility and effect of a program including information, counseling and an individualized physical activity program on physical and psychological health during and after chemotherapy in patients with testicular cancer. It is hypothesized that the patients are able to complete the intervention with individual adjustments.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Physical activity counseling | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Physical activity counseling | Behavioral |
|
| Measure | Description | Time Frame |
|---|---|---|
| Muscle strength, 1RM (one-repetition-maximum) | Change in 1RM from baseline to post-intervention and follow-up | Baseline (0 weeks), post-intervention (9-12 weeks) and follow-up (24 weeks) |
| Measure | Description | Time Frame |
|---|---|---|
| Cardio respiratory fitness (VO2max) | Change in VO2max from baseline to post-intervention and follow-up | Baseline (0 week), post-intervention (9-12 weeks) and follow-up (24 weeks) |
| Body composition (Lean body mass and fat mass) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Lene Thorsen, PhD | Oslo universty hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Oslo university hospital | Oslo | Norway |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 28619116 | Derived | Thorsen L, Kirkegaard C, Loge JH, Kiserud CE, Johansen ML, Gjerset GM, Edvardsen E, Hamre H, Ikdahl T, Fossa SD. Feasibility of a physical activity intervention during and shortly after chemotherapy for testicular cancer. BMC Res Notes. 2017 Jun 15;10(1):214. doi: 10.1186/s13104-017-2531-y. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D013736 | Testicular Neoplasms |
| D009043 | Motor Activity |
| ID | Term |
|---|---|
| D004701 | Endocrine Gland Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D005834 | Genital Neoplasms, Male |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Change in body composition from baseline to post-intervention and follow-up
| Baseline (0 week), post-intervention (9-12 weeks) and follow-up (24 weeks) |
| Metabolic disease markers (blood pressure, body mass index, glucose, high density lipoprotein cholesterol, triglycerides) | Change in metabolic disease markers from baseline to post-intervention and follow-up | Baseline (0 week), post-intervention (9-12 weeks) and follow-up (24 weeks) |
| C-reactive protein (CRP) | Change in CRP from baseline to post-intervention and follow-up | Baseline (0 week), post-intervention (9-12 weeks) and follow-up (24 weeks) |
| Creatinkinase (CK) | Change in CK from baseline to post-intervention and follow-up | Baseline (0 week), post-intervention (9-12 weeks) and follow-up (24 weeks) |
| Creatinkinase - MB (CK-MB) | Change in CK-MB from baseline to post-intervention and follow-up | Baseline (0 week), post-intervention (9-12 weeks) and follow-up (24 weeks) |
| Myoglobin | Change in myoglobin from baseline to post-intervention and follow-up | Baseline (0 week), post-intervention (9-12 weeks) and follow-up (24 weeks) |
| Work status | Change in work status from baseline to post-intervention and follow-up | Baseline (0 week), post-intervention (9-12 weeks) and follow-up (24 weeks) |
| Fatigue | Change in fatigue from baseline to post-intervention and follow-up | Baseline (0 week), post-intervention (9-12 weeks) and follow-up (24 weeks) |
| Anxiety and depression | Change in anxiety and depression from baseline to post-intervention and follow-up | Baseline (0 week), post-intervention (9-12 weeks) and follow-up (24 weeks) |
| Quality of life | Change in quality of life from baseline to post-intervention and follow-up | Baseline (0 week), post-intervention (9-12 weeks) and follow-up (24 weeks) |
| D014565 |
| Urogenital Neoplasms |
| D005832 | Genital Diseases, Male |
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| D004700 | Endocrine System Diseases |
| D013733 | Testicular Diseases |
| D006058 | Gonadal Disorders |
| D001519 | Behavior |